277 related articles for article (PubMed ID: 21692052)
21. Metabolic interrogation as a tool to optimize chemotherapeutic regimens.
Sandulache VC; Chen Y; Feng L; William WN; Skinner HD; Myers JN; Meyn RE; Li J; Mijiti A; Bankson JA; Fuller CD; Konopleva MY; Lai SY
Oncotarget; 2017 Mar; 8(11):18154-18165. PubMed ID: 28184025
[TBL] [Abstract][Full Text] [Related]
22. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
[TBL] [Abstract][Full Text] [Related]
23. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.
Lindemann A; Patel AA; Silver NL; Tang L; Liu Z; Wang L; Tanaka N; Rao X; Takahashi H; Maduka NK; Zhao M; Chen TC; Liu W; Gao M; Wang J; Frank SJ; Hittelman WN; Mills GB; Myers JN; Osman AA
Clin Cancer Res; 2019 Sep; 25(18):5650-5662. PubMed ID: 31308060
[TBL] [Abstract][Full Text] [Related]
24. Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.
Song A; Wu L; Zhang BX; Yang QC; Liu YT; Li H; Mao L; Xiong D; Yu HJ; Sun ZJ
Cancer Lett; 2024 Apr; 588():216727. PubMed ID: 38431035
[TBL] [Abstract][Full Text] [Related]
25. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Chang YC; Chi LH; Chang WM; Su CY; Lin YF; Chen CL; Chen MH; Chang PM; Wu AT; Hsiao M
J Hematol Oncol; 2017 Jan; 10(1):11. PubMed ID: 28061796
[TBL] [Abstract][Full Text] [Related]
26. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.
Coaxum SD; Tiedeken J; Garrett-Mayer E; Myers J; Rosenzweig SA; Neskey DM
Oncotarget; 2017 Apr; 8(14):22991-23007. PubMed ID: 28160562
[TBL] [Abstract][Full Text] [Related]
27. Head and Neck Squamous Cell Carcinoma Metabolism Draws on Glutaminolysis, and Stemness Is Specifically Regulated by Glutaminolysis via Aldehyde Dehydrogenase.
Kamarajan P; Rajendiran TM; Kinchen J; Bermúdez M; Danciu T; Kapila YL
J Proteome Res; 2017 Mar; 16(3):1315-1326. PubMed ID: 28168879
[TBL] [Abstract][Full Text] [Related]
28. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
29. The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma.
Guo S; Wang X; Wang Y; Bai J; Liu Y; Shao Z
Biomed Pharmacother; 2024 Jul; 176():116906. PubMed ID: 38876051
[TBL] [Abstract][Full Text] [Related]
30. Glucose and glutamine metabolism in oral squamous cell carcinoma: insight from a quantitative metabolomic approach.
Ogawa T; Washio J; Takahashi T; Echigo S; Takahashi N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Aug; 118(2):218-25. PubMed ID: 24927638
[TBL] [Abstract][Full Text] [Related]
31. Comparative metabolic analysis in head and neck cancer and the normal gingiva.
Voelxen NF; Blatt S; Knopf P; Henkel M; Appelhans C; Righesso LAR; Pabst A; Goldschmitt J; Walenta S; Neff A; Mueller-Klieser W; Ziebart T
Clin Oral Investig; 2018 Mar; 22(2):1033-1043. PubMed ID: 28735466
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.
Zhang XY; Li M; Sun K; Chen XJ; Meng J; Wu L; Zhang P; Tong X; Jiang WW
Oncotarget; 2015 Jan; 6(1):101-15. PubMed ID: 25575809
[TBL] [Abstract][Full Text] [Related]
33. p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer.
Cappello A; Tosetti G; Smirnov A; Ganini C; Yang X; Shi Y; Wang Y; Melino G; Bernassola F; Candi E
Biol Direct; 2023 Nov; 18(1):73. PubMed ID: 37946250
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma.
Wang L; Jiang H; Li W; Jia C; Zhang H; Sun Y; Chen X; Song X
Arch Oral Biol; 2017 Jan; 73():105-112. PubMed ID: 27744260
[TBL] [Abstract][Full Text] [Related]
35. Serum and tissue metabolomics of head and neck cancer.
Yonezawa K; Nishiumi S; Kitamoto-Matsuda J; Fujita T; Morimoto K; Yamashita D; Saito M; Otsuki N; Irino Y; Shinohara M; Yoshida M; Nibu K
Cancer Genomics Proteomics; 2013; 10(5):233-8. PubMed ID: 24136976
[TBL] [Abstract][Full Text] [Related]
36. Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.
Ziebart T; Walenta S; Kunkel M; Reichert TE; Wagner W; Mueller-Klieser W
J Cancer Res Clin Oncol; 2011 Feb; 137(2):193-9. PubMed ID: 20383719
[TBL] [Abstract][Full Text] [Related]
37. Energy metabolism in a matched model of radiation resistance for head and neck squamous cell cancer.
Mims J; Bansal N; Bharadwaj MS; Chen X; Molina AJ; Tsang AW; Furdui CM
Radiat Res; 2015 Mar; 183(3):291-304. PubMed ID: 25738895
[TBL] [Abstract][Full Text] [Related]
38. Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines.
Sakakibara A; Tsukuda M; Kondo N; Ishiguro Y; Kimura M; Fujita K; Takahashi H; Matsuda H
Auris Nasus Larynx; 2011 Oct; 38(5):589-99. PubMed ID: 21362583
[TBL] [Abstract][Full Text] [Related]
39. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
[TBL] [Abstract][Full Text] [Related]
40. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.
Wu X; Yeerna H; Goto Y; Ando T; Wu VH; Zhang X; Wang Z; Amornphimoltham P; Murphy AN; Tamayo P; Chen Q; Lippman SM; Gutkind JS
Cancer Res; 2019 Sep; 79(17):4360-4370. PubMed ID: 31292160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
